Opt Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Opt Health, Inc. - overview
Established
2019
Location
San Francisco, CA, US
Primary Industry
Healthcare IT
About
Based in California, US, Opt Health, Inc. is a telemedicine platform that offers a range of optimization services. Camilo Isaza (CEO), Greg Tidwell (CTO), and Samir Ghia (CLO) are the co-founders of the company. In August 2023, Opt Health, Inc.
raised USD 6. 88 million in venture funding from investors. The company offers a wide range of health optimization services, including peptide therapy, TRT, longevity medicine, epigenetic testing, and treatments for hair regrowth, erectile dysfunction, insulin resistance, and more. The firm connects men with health, wellness, strength, and sexual activity through doctor-guided health optimization programs.
Opt Health's health optimization is accomplished by a combination of blood tests to understand users' health, a personalized treatment plan, and a 1:1 physician visit to keep users on track. The organization generates revenue through its monthly pricing plans, which include the foundation plan for USD 95, the optimization plan for USD 245, and the longevity plan for USD 695.
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT
Website
www.getopt.com/
Verticals
HealthTech, Mobile Apps
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Opt Health, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.